Gene (new name) | Effect of deletion mutation on secretion | Effect on pedestal formation / virulence | Known interactions | Homologues | Domains | Known functions | New functional prediction |
---|---|---|---|---|---|---|---|
rorf1 | + | +/+ | EspD | YjiK | SdiA-regulated domain (NHL repeats) | Â | SdiA-regulated? |
espG | + | +/+ | Â | VirA | Â | Translocated effector | Â |
ler | No expression | -/- | Â | H-NS, StpA | Â | Positive regulator | Might form heterodimers with H-NS, StpA |
orf2 (escE) | - | Â | Orf29 | YscE, PscE, SsaE, CV2595, YPO0259 | Â | T3S | Interacts with C-terminus of SepL; Functionally important conserved residues can be identified by scrutiny of homologues |
cesAB | ± EspA, EspB | -/- | EspA, EspB | none |  | Chaperone for EspA and EspB |  |
orf4 | - | -/- | Â | YPO0264, SsaK, CV2589 | Â | T3S | Functionally important conserved residues can be identified by scrutiny of homologues |
orf5 (escL) | - | -/- | Â | YscL, FliH | Â | T3S | Binds to and regulates activity of ATPase EscN |
escR | - | -/- | EscR, EscS, EscU, SepZ EspD | YscR, FliP | PF00813 | T3S | Â |
escS | - | -/- | EscR, EspD | YscS, FliQ | PF01313 | T3S | Â |
escT | - | -/- | Â | YscT, FliR | PF01311 | T3S | Physically associated in the basal body with EscU in a 1:1 ratio; C-terminus is cytoplasmic [158] |
escU | - | -/- | EscrR, EscI, EspD | Yscu, FlhB | PF00771 | T3S | Physically associated in the basal body with EscT in a 1:1 ratio [158]; cleaved at NPTH motif [159]; regulates substrate specificity of secretion system [160]. |
rorf3 (etgA) | ± | ±/± | EscI | lytic transglycosylase IagB, IpgF |  |  | Lytic transglycosylase needed to open gap in peptidoglycan for assembly of secretion system [58]; potential drug target |
grIR | + | +/++ | GrlR/GrlA | Bongori regulator | Â | Negative regulator | Will work in concert with GrlA |
grIA | No expression | -/- | GrlR | Bongori regulator, CaiF | Â | Positive regulator | Will work in concert with GrlR |
cesD | -/EspD | ±/- |  | Other TPR chaperones |  | Chaperone for EspD | TPR chaperone [115] |
escC | - | -/- | EscD | YscC, MxiD, InvG | Â | T3S | Interacts with peptidoglycan [161], Dsb-dependent domain missing |
sepD | -/Translocators | -/- | SepL | None | Â | Switches translocator/effector secretion | Works in concert with SepL |
escJ | - | -/- | Â | YscJ, PrgK, FliF | PF01514 | T3S | EscD and EscJ form ring-like structure in inner membrane [66, 162, 163] |
rorf8 (escI) | - | -/- | EscU, rORF3 | PrgJ, MxiI, YscI | Â | T3S | Forms inner rod within base of needle complex [65, 68-70]. |
sepZ | + | +/± | EscR | None |  | Translocated effector |  |
orf12 | - | -/- | Â | SsaM | Â | T3S | Might play a role in switching translocator/effector secretion |
escN | - | -/- | CesT, Tir [50] | YscN | Â | T3S ATPAse | Forms hexameric complex |
escV | - | -/- | Â | LcrD, FlhA | PF00771 | T3S | C-terminal cytoplasmic domain might play a role in gene regulation [164, 165]. |
orf15 | - | -/- | Â | None | Â | T3S | Â |
orf16 | ±/Translocators | ±/± |  | None |  | Secretion of translocators | FliK/YscP analogue? |
sepQ (escQ) | - | -/- | Â | YscQ, FliN | COG1887 | T3S | Forms ring within basal body [56]; interacts with EscL [54] |
espH | + | +/++ | Â | Â | Â | Translocated effector | Â |
cesF | ±/EspF? | +/+ |  |  |  | Chaperone for EspF |  |
map | + | +/++ | CesT | Â | Â | Translocated effector | Â |
tir | + | -/- | CesT Tir | Â | Â | Translocated effector | Â |
cesT | ±/Tir | -/- | Map, EspF, Tir, CesT | Many |  | Chaperone for Tir | Possible regulatory role, by analogy with ExsC? |
eae | + | -/- | Â | Â | Â | Adhesin (intimin) | Â |
escD | - | -/- | Â | YscD, PrgH | YscD: FHA and BON domains | T3S | EscD and EscJ form ring-like structure in inner membrane [66, 162, 163]; BON domains mediate binding to phospholipids; FHA domain mediates protein-protein interactions and signalling |
sepL | -/Translocators | -/- | SepD | YopN, TyeA | Â | Switches translocator/effector secretion | single protein mediating effects of YopN and TyeA; internal interaction between YopN- and TyeA-like moieties; also a translocated effector? |
espA | + | -/- | CesAB | flagellin | Â | Translocator | Half-flagellin model (see text); dimerizes before polymerizes; lacks D0 and D3 domains |
espD | + | -/- | EspD, EscRSU, CesD, rORF1, SepZ | YopB etc | Â | Translocator | Â |
espB | + | -/- | CesAB | YopD etc | Â | Translocator | Â |
cesD2 | ±/EspD? | +/± |  | LcrR |  | Chaperone for EspD | LcrR will bind YopB |
escF | - | -/- | Â | YscF | Â | Major needle component | Â |
orf29 | - | -/- | Orf2 | YPO0261, SsaI, H, CV2586 | Â | T3S | Functionally important conserved residues can be identified by scrutiny of homologues |
espF | + | +/+ | Â | Â | Â | Translocated effector | Â |